Search
Boehringer_Ingelheim_Kurzbericht_2018.pdf
Boehringer_Ingelheim_Summary_Report_2018.pdf
Boehringer_Ingelheim_Unternehmensbericht_2018.pdf
Boehringer_Ingelheim_Kurzbericht_2015.pdf
Boehringer_Ingelheim_Summary_Report_2015.pdf
Boehringer_Ingelheim_Unternehmensbericht_2015.pdf
Boehringer_Ingelheim_Biosimilars.pdf
Boehringer_Ingelheim_consolidated_companies_2015.pdf
Boehringer_Ingelheim_Annual_Report_2015.pdf
Boehringer_Ingelheim_company_profile_2015.pdf
Boehringer_Ingelheim_Corporate_Factsheet.pdf
Boehringer_Ingelheim_Kurzbericht_2016.pdf
Boehringer_Ingelheim_Summary_Report_2016.pdf
Boehringer_Ingelheim_Annual_Report_2016.pdf
Boehringer_Ingelheim_Unternehmensbericht_2016.pdf
Boehringer_Ingelheim_Company_Profile_2017.pdf
Boehringer_Ingelheim_Consolidated_Companies_2016.pdf
FSA-Transparenzbericht Boehringer Ingelheim 2016.pdf
Global Network | Bioxcellence | Boehringer Ingelheim
Our network of manufacturing facilities spans the globe, from Fremont, in the United States to Biberach in Germany, Vienna in Austria and Shanghai in China
Monoclonal Antibody Production | Bioxcellence | Boehringer Ingelheim
Explore our advanced capabilities in antibody production, and learn about the unique features of monoclonal & polyclonal antibodies.
About Our Business| Bioxcellence | Boehringer Ingelheim
BioXcellence, reliable contract development & manufacturing partner to the pharmaceutical industry. A trusted partner through the Lifecyle of your product.
Media & News | Bioxcellence | Boehringer Ingelheim
Stay updated with BioXcellence Media & News. Explore the latest industry trends & news in global biopharmaceutical contract manufacturing. Don't miss out!
T-cell engagers: Reawakening T-cells to fight cancer
Learn how we are taking cancer on through our approach to immuno-oncology and our T-cell engagers plarform
Corporate volunteering boosts social impact - A win for all.
Boehringer Ingelheim corporate volunteers help people with disabilities. Volunteering has social impact and benefits employees, employers, and communities.